63 related articles for article (PubMed ID: 25661002)
21. CXC chemokine ligand 2 induced by receptor activator of NF-kappa B ligand enhances osteoclastogenesis.
Ha J; Choi HS; Lee Y; Kwon HJ; Song YW; Kim HH
J Immunol; 2010 May; 184(9):4717-24. PubMed ID: 20357249
[TBL] [Abstract][Full Text] [Related]
22. Adenovirus-mediated small interfering RNA targeting tumor necrosis factor-α inhibits titanium particle-induced osteoclastogenesis and bone resorption.
Guo H; Zhang J; Hao S; Jin Q
Int J Mol Med; 2013 Aug; 32(2):296-306. PubMed ID: 23760678
[TBL] [Abstract][Full Text] [Related]
23. Myricetin prevents titanium particle-induced osteolysis in vivo and inhibits RANKL-induced osteoclastogenesis in vitro.
Wu C; Wang W; Tian B; Liu X; Qu X; Zhai Z; Li H; Liu F; Fan Q; Tang T; Qin A; Zhu Z
Biochem Pharmacol; 2015 Jan; 93(1):59-71. PubMed ID: 25449599
[TBL] [Abstract][Full Text] [Related]
24. β-Adrenergic signaling stimulates osteoclastogenesis via reactive oxygen species.
Kondo H; Takeuchi S; Togari A
Am J Physiol Endocrinol Metab; 2013 Mar; 304(5):E507-15. PubMed ID: 23169789
[TBL] [Abstract][Full Text] [Related]
25. Viral interleukin-10 gene inhibition of inflammation, osteoclastogenesis, and bone resorption in response to titanium particles.
Carmody EE; Schwarz EM; Puzas JE; Rosier RN; O'Keefe RJ
Arthritis Rheum; 2002 May; 46(5):1298-308. PubMed ID: 12115237
[TBL] [Abstract][Full Text] [Related]
26. Expression and localization of extracellular matrix metalloproteinase inducer in giant cell tumor of bone.
Si AI; Huang L; Xu J; Kumta SM; Wood D; Zheng MH
J Cell Biochem; 2003 Aug; 89(6):1154-63. PubMed ID: 12898514
[TBL] [Abstract][Full Text] [Related]
27. Jolkinolide B inhibits RANKL-induced osteoclastogenesis by suppressing the activation NF-κB and MAPK signaling pathways.
Ma X; Liu Y; Zhang Y; Yu X; Wang W; Zhao D
Biochem Biophys Res Commun; 2014 Mar; 445(2):282-8. PubMed ID: 24491533
[TBL] [Abstract][Full Text] [Related]
28. High extracellular Ca2+ alone stimulates osteoclast formation but inhibits in the presence of other osteoclastogenic factors.
Shin MM; Kim YH; Kim SN; Kim GS; Baek JH
Exp Mol Med; 2003 Jun; 35(3):167-74. PubMed ID: 12858015
[TBL] [Abstract][Full Text] [Related]
29. Receptor activator of NF-kappaB ligand induces the expression of carbonic anhydrase II, cathepsin K, and matrix metalloproteinase-9 in osteoclast precursor RAW264.7 cells.
Fujisaki K; Tanabe N; Suzuki N; Kawato T; Takeichi O; Tsuzukibashi O; Makimura M; Ito K; Maeno M
Life Sci; 2007 Mar; 80(14):1311-8. PubMed ID: 17306833
[TBL] [Abstract][Full Text] [Related]
30. Two distinct cellular mechanisms of osteoclast formation and bone resorption in periprosthetic osteolysis.
Sabokbar A; Kudo O; Athanasou NA
J Orthop Res; 2003 Jan; 21(1):73-80. PubMed ID: 12507582
[TBL] [Abstract][Full Text] [Related]
31. Inhibition of osteoclastogenic differentiation by Ikarisoside A in RAW 264.7 cells via JNK and NF-kappaB signaling pathways.
Choi HJ; Park YR; Nepal M; Choi BY; Cho NP; Choi SH; Heo SR; Kim HS; Yang MS; Soh Y
Eur J Pharmacol; 2010 Jun; 636(1-3):28-35. PubMed ID: 20353769
[TBL] [Abstract][Full Text] [Related]
32. Maslinic acid suppresses osteoclastogenesis and prevents ovariectomy-induced bone loss by regulating RANKL-mediated NF-κB and MAPK signaling pathways.
Li C; Yang Z; Li Z; Ma Y; Zhang L; Zheng C; Qiu W; Wu X; Wang X; Li H; Tang J; Qian M; Li D; Wang P; Luo J; Liu M
J Bone Miner Res; 2011 Mar; 26(3):644-56. PubMed ID: 20814972
[TBL] [Abstract][Full Text] [Related]
33. IL-12 Inhibits Lipopolysaccharide Stimulated Osteoclastogenesis in Mice.
Yoshimatsu M; Kitaura H; Fujimura Y; Kohara H; Morita Y; Yoshida N
J Immunol Res; 2015; 2015():214878. PubMed ID: 26064997
[TBL] [Abstract][Full Text] [Related]
34. CD147 promotes the proliferation, invasiveness, migration and angiogenesis of human lung carcinoma cells.
Yang S; Qi F; Tang C; Wang H; Qin H; Li X; Li J; Wang W; Zhao C; Gao H
Oncol Lett; 2017 Feb; 13(2):898-904. PubMed ID: 28356976
[TBL] [Abstract][Full Text] [Related]
35. Monocyte chemotactic protein 1 promotes lung cancer-induced bone resorptive lesions in vivo.
Cai Z; Chen Q; Chen J; Lu Y; Xiao G; Wu Z; Zhou Q; Zhang J
Neoplasia; 2009 Mar; 11(3):228-36. PubMed ID: 19242604
[TBL] [Abstract][Full Text] [Related]
36. B lymphocytes inhibit human osteoclastogenesis by secretion of TGFbeta.
Weitzmann MN; Cenci S; Haug J; Brown C; DiPersio J; Pacifici R
J Cell Biochem; 2000 May; 78(2):318-24. PubMed ID: 10842325
[TBL] [Abstract][Full Text] [Related]
37. A Competitive ELISA for quantifying serum CD147: reduction of soluble CD147 levels in cancer patient sera.
Moonsom S; Tayapiwatana C; Wongkham S; Kongtawelert P; Kasinrerk W
Hybridoma (Larchmt); 2010 Feb; 29(1):45-52. PubMed ID: 20199151
[TBL] [Abstract][Full Text] [Related]
38. Nuclear envelope-distributed CD147 interacts with and inhibits the transcriptional function of RING1 and promotes melanoma cell motility.
Chen J; Peng C; Lei L; Zhang J; Zeng W; Chen X
PLoS One; 2017; 12(8):e0183689. PubMed ID: 28832687
[TBL] [Abstract][Full Text] [Related]
39. System analysis of the regulation of the immune response by CD147 and FOXC1 in cancer cell lines.
Shang YK; Li C; Liu ZK; Kong LM; Wei D; Xu J; Wang ZL; Bian H; Chen ZN
Oncotarget; 2018 Feb; 9(16):12918-12931. PubMed ID: 29560120
[TBL] [Abstract][Full Text] [Related]
40. Combination Therapy With CD147-Targeted Nanoparticles Carrying Phenformin Decreases Lung Cancer Growth.
Pereira-Nunes A; Ferreira H; Abreu S; Guedes M; Neves NM; Baltazar F; Granja S
Adv Biol (Weinh); 2023 Jul; 7(7):e2300080. PubMed ID: 37303292
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
